Bemedozone solution for injection 4mg/ml 1ml No. 5

Bemedazone is a corticosteroid for systemic use. Betamethasone for use in

Warehouse

Contraindication

Systemic mycoses.

Hypersensitivity to betamethasone, to other components of the drug or to other glucocorticosteroids.

Method of application

The initial dose for adults is up to 8 mg of betamethasone per day. In less severe cases, the drug can be used in lower doses. If necessary, the initial single doses can be increased. The initial dose should be adjusted until a satisfactory clinical response is obtained. If a clinical result is not achieved after a certain period of time, betamethasone should be discontinued and the therapy reviewed.

For children, the usual starting intramuscular dose of betamethasone is 20-125 mcg/kg body weight per day. Dosage for younger and older children should be established according to the same principles as for adults (preferably strictly adhering to the doses indicated for age and body weight).

Application features

Corticosteroids should be administered with caution to patients who have recently had a myocardial infarction due to the risk of myocardial rupture.

Due to insufficient data on the use of corticosteroids for the treatment of head injury or stroke, they should not be used for these conditions.

Pregnant women

The safety of the drug during pregnancy has not been established, therefore Betamethasone should be used during this period only if the expected benefit to the mother outweighs the possible risk to the fetus.

Children

Can be used by children.

Drivers

It is recommended to refrain from driving or operating machinery during treatment with the drug.

Overdose

Acute overdose of corticosteroids, including betamethasone, is not expected to be life-threatening. Except in very large doses, excessive use of corticosteroids is unlikely to cause adverse effects unless there are specific contraindications, such as diabetes, glaucoma, active peptic ulcer disease, and the patient is not taking digitalis, coumarin anticoagulants, or potassium-sparing diuretics.

Side effects

Cardiovascular system: congestive heart failure in patients predisposed to this disease; arterial hypertension.

Nervous system: dizziness, headache, convulsions, increased intracranial pressure with swelling of the optic nerve discs (pseudotumor cerebri), usually after completion of treatment, migraine.

On the part of the psyche: euphoria, psychoemotional instability, mood swings, severe depression up to the appearance of frank psychotic reactions, particularly in patients with a psychiatric history, personality changes, increased irritability, insomnia.

On the part of the organs of vision: subcapsular posterior cataract, increased intraocular pressure, glaucoma, exophthalmos.

Storage conditions

Store in original packaging at a temperature not exceeding 25°C. Do not freeze.

Keep out of reach of children.